September 11, 2018 06:16 AM EDT
Pharma

No­var­tis makes it of­fi­cial: Al­con is mov­ing its HQ from Texas to Gene­va ahead of a spin­off

John Carroll

Editor & Founder

Al­con is los­ing its Texas ac­cent.

No­var­tis $NVS CEO Vas Narasimhan put out the word this morn­ing that the Basel-based phar­ma gi­ant is mov­ing Al­con …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA of­fers suite of new guid­ance on AI, ac­cel­er­at­ed ap­provals, clin­i­cal tri­als and more

WuXi Bi­o­log­ics to sell Irish vac­cine site to Mer­ck for $500M

Every FDA drug ap­proval from 2024: Few­er nods, but long-await­ed treat­ments cross the fin­ish line

'Mi­cro­pro­tein' biotech Velia, backed by TCG and Fore­site, to wind down

Ex­clu­sive: Joe Jimenez's Adi­tum Bio rings in new year with $428M third fund

An­them Bio­sciences eyes $397M pub­lic of­fer­ing in In­dia

A service from the Financial Times